Login / Signup

First add-on perampanel for focal-onset seizures: An open-label, prospective study.

Ji Hyun KimDong Wook KimSang Kun LeeDae Won SeoJi Woong LeeHae Joon ParkSang-Ahm Lee
Published in: Acta neurologica Scandinavica (2019)
Perampanel was effective and well tolerated as a first add-on to monotherapy in patients with focal-onset seizures, with or without secondarily generalized seizures.
Keyphrases
  • temporal lobe epilepsy
  • combination therapy
  • randomized controlled trial
  • clinical trial
  • double blind